Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/19/1998 | WO1998006378A1 Anti-seborrheic guanidine salts |
02/19/1998 | WO1998006278A1 Methods and compositions for increasing the anaerobic working capacity in tissues |
02/19/1998 | WO1998006266A1 Antiviral materials |
02/19/1998 | WO1998006265A2 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine |
02/19/1998 | WO1998006262A1 Il-8 receptor antagonists |
02/19/1998 | WO1998006261A1 Methods of treating pulmonary diseases mediated by polyunsaturated lipid metabolites and assays for epoxide hydrolase inhibitors |
02/19/1998 | WO1998001571A3 Erythromycins and process for their preparation |
02/19/1998 | WO1998001124A3 Pharmaceutical preparation containing nimesulide for topical use |
02/19/1998 | WO1997048408A3 Method for the prevention and treatment of mastitis |
02/19/1998 | WO1997048385A3 Controlled release tablet |
02/19/1998 | WO1997048382A3 Multiple-unit type prolonged action drug preparation |
02/19/1998 | WO1997046208A3 Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
02/19/1998 | WO1997042979A3 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
02/19/1998 | WO1997041243A3 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
02/19/1998 | WO1997039120A3 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
02/19/1998 | WO1997038085A3 Genes amplified in cancer cells |
02/19/1998 | DE19719522A1 New poly:cyclic phthalazine compounds (madura:phthalazine derivatives) |
02/19/1998 | DE19632840A1 Vitamin A-haltige Zusammensetzung Vitamin A-containing composition |
02/19/1998 | DE19632772A1 Neue Benzamidine New benzamidines |
02/19/1998 | DE19632549A1 Arylalkanoylpyridazine Arylalkanoylpyridazine |
02/19/1998 | DE19632423A1 Thienopyrimidine Thienopyrimidines |
02/19/1998 | CA2264104A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
02/19/1998 | CA2263550A1 Treatment of the common cold or allergic rhinitis |
02/19/1998 | CA2263489A1 Slow-onset, long-lasting dopamine reuptake blockers |
02/19/1998 | CA2263388A1 Il-8 receptor antagonists |
02/19/1998 | CA2263366A1 Use of efaroxan for producing medicine for treating huntington disease |
02/19/1998 | CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor |
02/19/1998 | CA2263325A1 Pharmaceutical compositions comprising tyrphostins |
02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
02/19/1998 | CA2263311A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
02/19/1998 | CA2263284A1 Tetrahydroisoquinoline derivatives and their pharmaceutical use |
02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
02/19/1998 | CA2263165A1 Human induced tumor protein |
02/19/1998 | CA2263163A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
02/19/1998 | CA2263100A1 Pharmaceutically active compounds and methods of use |
02/19/1998 | CA2263077A1 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound |
02/19/1998 | CA2262686A1 Thrombin inhibitors |
02/19/1998 | CA2262676A1 Stereoselective deoxygenation reaction |
02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
02/19/1998 | CA2262117A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
02/19/1998 | CA2261752A1 Preparation of aminomethyl-phenylimidazoles |
02/19/1998 | CA2260872A1 Substituted pyrimidine derivatives and their pharmaceutical use |
02/19/1998 | CA2260854A1 Modified oligosaccharides |
02/19/1998 | CA2234245A1 Tablet of isotope-labeled urea |
02/19/1998 | CA2213285A1 Novel polyene antibiotics, 3874 h1 to h6, processes for their preparation and use |
02/18/1998 | EP0824098A1 4-hydroxy-piperidine derivatives |
02/18/1998 | EP0823996A1 Anti-infective against STD relating, for example, to HIV, Chlamydia, gonococcus, treponema pallidum or herpes simplex and device used to preserve/mix principal ingredient and base of such anti-infective |
02/18/1998 | EP0823942A1 Efflux pump inhibitors |
02/18/1998 | EP0823913A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
02/18/1998 | EP0823912A1 Azacycloalcane derivatives, preparation thereof and their applications in therapy |
02/18/1998 | EP0823911A1 Esters of carbapenems |
02/18/1998 | EP0823910A1 Esters of carbapenems |
02/18/1998 | EP0823909A1 Novel heterocyclic chemistry |
02/18/1998 | EP0823908A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
02/18/1998 | EP0823907A1 NEW PROCESS FOR PREPARING (-)-TRANS-N-p-FLUOROBENZOYLMETHYL-4-(p-FLUOROPHENYL)-3- 3,4-(METHYLENEDIOXY)PHENOXY]METHYL]-PIPERIDINE |
02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
02/18/1998 | EP0823905A1 Novel heterocyclic chemistry |
02/18/1998 | EP0823903A1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
02/18/1998 | EP0823901A1 Quinazoline derivative |
02/18/1998 | EP0823900A1 Quinazoline derivatives |
02/18/1998 | EP0823897A1 Nicotinic acid esters and pharmaceutical compositions containing them |
02/18/1998 | EP0823896A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
02/18/1998 | EP0823893A1 Novel tetracycline derivatives |
02/18/1998 | EP0823892A1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma |
02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
02/18/1998 | EP0770381B1 Support and composition containing it together with a stabilised cosmetic or dermatologic agent |
02/18/1998 | EP0719252B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
02/18/1998 | EP0719148B1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
02/18/1998 | EP0695177B1 Active substance-containing plaster |
02/18/1998 | EP0561939B1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
02/18/1998 | CN1173868A Thienopyrimidine derivatives, their production and use |
02/18/1998 | CN1173864A Sulfamate compounds containing n -substituted carbanoyl and process for preparing the same |
02/18/1998 | CN1173821A Methods of inhibiting cell-cell adhesion |
02/18/1998 | CN1173820A Pharmaceutical composition for the treatment of herpes |
02/18/1998 | CN1173819A Methods of inhibiting effects of IL_6 |
02/18/1998 | CN1173818A Pharmaceutical preparations for tumour necrosis factor (TNF) inhibition |
02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
02/18/1998 | CN1173816A Oral dosage-forms containing a'beta'-lactam antibiotic |
02/18/1998 | CN1173815A Liposome formulations of 5'beta' steroids |
02/18/1998 | CN1173497A Heterocycle-containing carbonic acid derivatives |
02/18/1998 | CN1173345A 一种治疗胃病的药物——胃净 A treatment for stomach medicine - stomach Net |
02/18/1998 | CN1173331A Process for production of anthelmintic composition for animal use |
02/18/1998 | CN1173330A Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors |
02/18/1998 | CN1173329A Health Vitamin B6 Cigarette Plaster and its prepn. method |
02/18/1998 | CN1173328A Use of medicinal feed for systemic treatment of fish diseases |
02/18/1998 | CN1173324A Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and uses thereof |
02/18/1998 | CN1037443C Method of prepn. of phosostigmine carbamate derivatives from physostigmine |
02/18/1998 | CN1037442C Process for obtaining 3, 7 -dialkylxanthines from 3 -alkyl -xanthines |
02/18/1998 | CN1037441C Bicyclic amine derivatives and herbicides containing the same |
02/18/1998 | CN1037440C Method for prepn. of angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones |
02/18/1998 | CN1037439C Method for prepn. fo neuroprotective indolone and related derivatives |
02/18/1998 | CN1037438C Method for prepn. of chroman and thiochroman derivatives |
02/18/1998 | CN1037405C Spray medicinal film for gullet |
02/17/1998 | US5719306 LTA4 hydrolase inhibitors |
02/17/1998 | US5719303 Phosphonic acid derivatives |
02/17/1998 | US5719287 Intermediates for inhibitors of HIV protease and method of preparation thereof |
02/17/1998 | US5719286 Optical pure chemical intermediates |
02/17/1998 | US5719279 Cholinomimetics |